Colgate-Palmolive (CL) Expected to Announce Quarterly Sales of $4.01 Billion

Brokerages expect Colgate-Palmolive (NYSE:CL) to post $4.01 billion in sales for the current quarter, according to Zacks Investment Research. Eight analysts have made estimates for Colgate-Palmolive’s earnings. The highest sales estimate is $4.09 billion and the lowest is $3.95 billion. Colgate-Palmolive reported sales of $3.76 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 6.6%. The company is expected to report its next earnings results on Friday, April 27th.

According to Zacks, analysts expect that Colgate-Palmolive will report full-year sales of $4.01 billion for the current fiscal year, with estimates ranging from $16.09 billion to $16.57 billion. For the next financial year, analysts forecast that the firm will post sales of $16.82 billion per share, with estimates ranging from $16.62 billion to $17.14 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter last year, the firm earned $0.75 earnings per share. The business’s revenue was up 4.6% on a year-over-year basis.

CL has been the topic of several research reports. Citigroup cut their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Monday, October 23rd. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $77.71.

Colgate-Palmolive (CL) opened at $69.76 on Thursday. The company has a debt-to-equity ratio of 24.42, a current ratio of 0.47 and a quick ratio of 0.34. The firm has a market capitalization of $61,260.00, a price-to-earnings ratio of 30.60, a P/E/G ratio of 2.58 and a beta of 0.75. Colgate-Palmolive has a 52-week low of $66.47 and a 52-week high of $77.91.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.29%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 70.18%.

In other news, Vice Chairman Franck J. Moison sold 142,979 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the sale, the insider now directly owns 224,027 shares of the company’s stock, valued at $15,702,052.43. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Henning I. Jakobsen sold 36,215 shares of Colgate-Palmolive stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $71.22, for a total value of $2,579,232.30. Following the sale, the vice president now directly owns 70,783 shares in the company, valued at $5,041,165.26. The disclosure for this sale can be found here. Insiders sold 327,451 shares of company stock worth $23,534,707 over the last three months. 1.02% of the stock is currently owned by corporate insiders.

A number of large investors have recently bought and sold shares of CL. Jacobi Capital Management LLC grew its stake in Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Krilogy Financial LLC grew its stake in Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors acquired a new position in Colgate-Palmolive in the second quarter worth about $122,000. AlphaMark Advisors LLC grew its stake in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC acquired a new position in Colgate-Palmolive in the second quarter worth about $126,000. Institutional investors and hedge funds own 73.10% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Expected to Announce Quarterly Sales of $4.01 Billion” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/08/colgate-palmolive-cl-expected-to-announce-quarterly-sales-of-4-01-billion.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply